Cloning and gene expression of G protein competitive inhibitory polypeptide and its prophylactic effects on myocardial hypertrophy in vitro

Acta Pharmacologica Sinica

Volumn 24, Issue 11, 2003, Pages 1108-1112+1173

  Zhou, Jian Zhi ^a   Li, Xiao Hui ^a   Zhang, Hai Gang ^a   Tang, Yuan ^a   Wang, Xiao Qin ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gene expression; Genetic vectors; GTP binding proteins; Left ventricular hypertrophy; Plasmids

Indexed keywords

AGAROSE; G PROTEIN COMPETITIVE INHIBITORY POLYPEPTIDE; OLIGONUCLEOTIDE; PLASMID VECTOR; POLYPEPTIDE; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ISOLATION; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SYNTHESIS; GENE CONSTRUCT; GENE EXPRESSION; GENE INSERTION; HEART VENTRICLE HYPERTROPHY; IN VITRO STUDY; MOLECULAR CLONING; NEWBORN; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROPHYLAXIS; PROTEIN CONTENT; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; RAT; RECOMBINANT PLASMID; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; CLONING, MOLECULAR; ESCHERICHIA COLI; GENE EXPRESSION; GENETIC VECTORS; GTP-BINDING PROTEINS; LEUCINE; MOLECULAR WEIGHT; MYOCYTES, CARDIAC; PLASMIDS; RATS; RATS, WISTAR; RECOMBINANT PROTEINS;

EID: 0242473894     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Zolk O, Kouchi I, Schnabel P, Bohm M. Heterotrimeric G proteins in heart disease. Can J Physiol Pharmacol 2000; 78: 187-98.
2. Schnabel P, Bohm M. Heterotrimeric G proteins in heart disease. Cell Signal 1996; 8: 413-23.
3. Walter JK, Carmelo AM, Robert JL. Transgenic manipulation of myocardial G protein-coupled receptors and receptor kinases. Circ Res 1996; 78: 511-6.
4. Milano CA, Dolber PC, Rockman HA, Bond RA, Venable ME, Allen LF, et al. Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc Natl Acad Sci USA 1994; 91: 10109-13.
5. Milano CA, Allen LF, Rockman HA, Dolber PC, McMinn TR, Chien KR, et al. Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. Science 1994; 264: 582-6.
6. Koch WJ, Rockman HA, Samama P, Hamilton RA, Bond RA, Milano CA, et al. Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. Science 1995; 268: 1350-3.
7. Shahab AA, Louis ML, Howard AR, Guido I, Robert JL, Walter JK. Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science 1998; 280: 574-7.
8. Sun HY, Liu XH, Liang SW. Gene construction, expression, and characterization of double-copy truncated form of human insulin-like growth factor I. Acta Pharmacol Sin 2001; 22: 624-8.
9. Kratzin HD, Wiltfang J, Karas M, Neuhoff V, Hilschmann N. Gas-phase sequencing after electroblotting on polyvinylidene difluoride membranes assigns correct molecular weights to myoglobin molecular weight markers. Anal Biochem 1989; 183: 1-8.
10. Simpson P. Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response. J Clin Invest 1983; 72: 732-8.
11. Deng XF, Rokosh DG, Simpson PC. Autonomous and growth factor-induced hypertrophy in cultured neonatal mouse cardiac myocytes comparison with rat. Circ Res 2000; 87: 781-8.
12. Scheuer J. Catecholamines in cardiac hypertrophy. Am J Cardiol 1999; 83: 70-4.
13. Rapacciuolo A, Esposito G, Prasad SV, Rockman HA. G protein-coupled receptor signalling in in vivo cardiac overload. Acta Physiol Scand 2001; 173: 51-7.